The ASCO annual meeting is widely considered one of the largest and most prestigious cancer research conferences in the world. From May 30 to June 3, more than 40,000 oncology professionals will ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

At ASCO, our presentations showcase how we are seeking to further transform the treatment of these diseases with updates from two key programs – our Phase 3 trial exploring adjuvant Libtayo in ...

The annual meeting of the American Society of Clinical Oncology is the most visible showcase for new cancer drug data. Join industry leaders, scientific experts, and STAT reporters for an ...

An interview with Mark Lanasa, MD, PhD, BeiGene senior vice president and chief medical officer for solid tumors, conducted at ASCO 2024. Ishwaria Subbiah, MD, of SCRI Oncology Partners ...

Gilead Sciences’ bid to extend the uses of TROP2-directed Trodelvy into lung cancer currently rests on the results of its EVOKE-01 study, revealed for the first time at this year’s ASCO.

This year’s ASCO meeting — themed “Driving Knowledge to Action. Building a Better Future” — unites nearly 45,000 oncology professionals to discuss leading-edge scientific data and attend ...

Regeneron Pharmaceuticals, Inc. announced that it will present new and updated data from its oncology and hematology portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reported at the ASCO congress.

The Association for Clinical Oncology (ASCO) is carefully reviewing the Administration’s Fiscal Year 2026 “skinny” budget proposal, which was released May 2 and contains significant cuts to federal ...